News on Bardet-Biedl_Syndrome from BioPortfolio.com http://www.BioPortfolio.com Consolidated Bardet-Biedl_Syndrome news from BioPortfolio.com Wed, 10 Feb 2010 16:03:19 GMT en Report on global acute coronary syndrome disease markethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043272&HITNO=0&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043272&THISHREF=http://c.moreover.com/click/here.pl%3fz2539671973%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043272&HITNO=0&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043272&THISHREF=http://c.moreover.com/click/here.pl%3fz2539671973%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Research and Markets: Acute Coronary Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041184&HITNO=1&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041184&THISHREF=http://c.moreover.com/click/here.pl%3fz2539024659%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041184&HITNO=1&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041184&THISHREF=http://c.moreover.com/click/here.pl%3fz2539024659%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire via Yahoo!: Acute Coronary Syndrome Drug Pipeline Analysis and Market Forecasts to 2016http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041777&HITNO=2&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041777&THISHREF=http://c.moreover.com/click/here.pl%3fz2539224090%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041777&HITNO=2&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041777&THISHREF=http://c.moreover.com/click/here.pl%3fz2539224090%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYour Story: Seaside Therapeutics Announces Issuance of Key Patent for Treatment of Autism Spectrum Disordershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042619&HITNO=3&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042619&THISHREF=http://c.moreover.com/click/here.pl%3fz2539479889%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042619&HITNO=3&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042619&THISHREF=http://c.moreover.com/click/here.pl%3fz2539479889%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Seaside Therapeutics granted U.S patent covering methods of treating autismhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042200&HITNO=4&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042200&THISHREF=http://c.moreover.com/click/here.pl%3fz2539352565%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042200&HITNO=4&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042200&THISHREF=http://c.moreover.com/click/here.pl%3fz2539352565%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Research and Markets: Acute Coronary Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041265&HITNO=5&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041265&THISHREF=http://c.moreover.com/click/here.pl%3fz2539053707%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041265&HITNO=5&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041265&THISHREF=http://c.moreover.com/click/here.pl%3fz2539053707%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: Research and Markets: Acute Coronary Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041206&HITNO=6&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041206&THISHREF=http://c.moreover.com/click/here.pl%3fz2539033677%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041206&HITNO=6&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041206&THISHREF=http://c.moreover.com/click/here.pl%3fz2539033677%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: Research and Markets: Acute Coronary Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041249&HITNO=7&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041249&THISHREF=http://c.moreover.com/click/here.pl%3fz2539048511%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041249&HITNO=7&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041249&THISHREF=http://c.moreover.com/click/here.pl%3fz2539048511%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Research and Markets: Acute Coronary Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041245&HITNO=8&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041245&THISHREF=http://c.moreover.com/click/here.pl%3fz2539047804%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041245&HITNO=8&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041245&THISHREF=http://c.moreover.com/click/here.pl%3fz2539047804%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 ...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039357&HITNO=9&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039357&THISHREF=http://c.moreover.com/click/here.pl%3fz2538057086%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039357&HITNO=9&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039357&THISHREF=http://c.moreover.com/click/here.pl%3fz2538057086%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPipelineReview: History of AIDShttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043249&HITNO=10&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043249&THISHREF=http://c.moreover.com/click/here.pl%3fz2539663960%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043249&HITNO=10&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043249&THISHREF=http://c.moreover.com/click/here.pl%3fz2539663960%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedicineNet.com: Munchausen Syndromehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043244&HITNO=11&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043244&THISHREF=http://c.moreover.com/click/here.pl%3fz2539662824%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043244&HITNO=11&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043244&THISHREF=http://c.moreover.com/click/here.pl%3fz2539662824%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedicineNet.com: QR Pharma Initiates Clinical Trial for Cognitively Impaired Patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042625&HITNO=12&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042625&THISHREF=http://c.moreover.com/click/here.pl%3fz2539481744%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042625&HITNO=12&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042625&THISHREF=http://c.moreover.com/click/here.pl%3fz2539481744%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: QR Pharma Initiates Clinical Trial for Cognitively Impaired Patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042196&HITNO=13&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042196&THISHREF=http://c.moreover.com/click/here.pl%3fz2539351891%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042196&HITNO=13&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042196&THISHREF=http://c.moreover.com/click/here.pl%3fz2539351891%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: QR Pharma Initiates Clinical Trial for Cognitively Impaired Patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041585&HITNO=14&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041585&THISHREF=http://c.moreover.com/click/here.pl%3fz2539174665%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041585&HITNO=14&MSIZE=995&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bardet-Biedl_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041585&THISHREF=http://c.moreover.com/click/here.pl%3fz2539174665%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: